Last reviewed · How we verify
Extra Blood Draw
At a glance
| Generic name | Extra Blood Draw |
|---|---|
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Siemens Biomarker Multi-modality (NA)
- DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE (NA)
- Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis (PHASE1)
- Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome
- Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
- Shunt-dependency After aSAH - Role of Early Hyperglycaemia in CSF and Blood
- Biological Collection for Marfan and Related Syndromes
- Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Extra Blood Draw CI brief — competitive landscape report
- Extra Blood Draw updates RSS · CI watch RSS
- Assistance Publique Hopitaux De Marseille portfolio CI